Risk modeling in cardiomyopathies
1:05:44
Risk modeling in cardiomyopathies
5 ай бұрын
The complex spectrum of Mendelian genetics in cardiomyopathies
59:05
The complex spectrum of Mendelian genetics in cardiomyopathies
9 ай бұрын
Emerging Therapies for TransthyretinCardiac Amyloidosis
56:34
Emerging Therapies for TransthyretinCardiac Amyloidosis
10 ай бұрын
Functional studies on Z-disc proteins and their role in cardiomyopathies
58:22
Functional studies on Z-disc proteins and their role in cardiomyopathies
Жыл бұрын
Exercise recommendations in cardiomyopathies
56:28
Exercise recommendations in cardiomyopathies
Жыл бұрын
Cardiac outcomes in mitochondrial disease
56:12
Cardiac outcomes in mitochondrial disease
Жыл бұрын
The importance of the genotype on top of phenotype in managing dilated cardiomyopathies.
56:26
The importance of the genotype on top of phenotype in managing dilated cardiomyopathies.
Жыл бұрын
Tracking and treating heart muscle inflammation.
1:02:23
Tracking and treating heart muscle inflammation.
2 жыл бұрын
Association between prophylactic ACEinhibitors and overall survival in Duchennemuscular dystrophy
58:43
Association between prophylactic ACEinhibitors and overall survival in Duchennemuscular dystrophy
2 жыл бұрын
Population prevalence of premature truncating variants in PKP2 and association with ARVC.
58:57
Population prevalence of premature truncating variants in PKP2 and association with ARVC.
2 жыл бұрын
We see, but do not observe. Arrhythmogenic Cardiomyopathy revisited.
59:16
We see, but do not observe. Arrhythmogenic Cardiomyopathy revisited.
2 жыл бұрын
State-of-the-art human models to test effectiveness of old and new drugs for cardiomyopathies
1:03:41
State-of-the-art human models to test effectiveness of old and new drugs for cardiomyopathies
2 жыл бұрын
Natural History of HCM in NoonanSyndrome with MultipleLentigines (LEOPARD Syndrome)
9:52
Natural History of HCM in NoonanSyndrome with MultipleLentigines (LEOPARD Syndrome)
2 жыл бұрын
Genetics in Arrhythmogenic Cardiomyopathy and implications for clinical practice
32:44
Genetics in Arrhythmogenic Cardiomyopathy and implications for clinical practice
3 жыл бұрын
Genetic Variants and outcomes in non-ischaemic dilated cardiomyopathy
16:11
Genetic Variants and outcomes in non-ischaemic dilated cardiomyopathy
3 жыл бұрын
Clinical characteristics and natural history of childhood HCM - does age of onset matter?
10:38
Clinical characteristics and natural history of childhood HCM - does age of onset matter?
3 жыл бұрын
Show me the ECG and I'll tell you everything you want to know! (or almost)
34:59
Show me the ECG and I'll tell you everything you want to know! (or almost)
3 жыл бұрын
hiPSCs for personalised medicine in inherited cardiomyopathies - Heart Muscle Talks
30:07
hiPSCs for personalised medicine in inherited cardiomyopathies - Heart Muscle Talks
3 жыл бұрын
Clinical implications of cardiomyocyte electrophysiological remodelling in HOCM
14:32
Clinical implications of cardiomyocyte electrophysiological remodelling in HOCM
3 жыл бұрын
Natural history of dilated cardiomyopathy caused by FLNC truncating variants-ICON Heart Muscle Talks
16:47
Natural history of dilated cardiomyopathy caused by FLNC truncating variants-ICON Heart Muscle Talks
3 жыл бұрын
Prevented SCD and neurological recovery in IHD - Heart Muscle Talks
10:55
Prevented SCD and neurological recovery in IHD - Heart Muscle Talks
3 жыл бұрын
5-year follow-up of patients with recent onset unexplained DCM undergoing end-myocardial biopsy
13:10
5-year follow-up of patients with recent onset unexplained DCM undergoing end-myocardial biopsy
3 жыл бұрын
Пікірлер
@chrisboy28
@chrisboy28 3 жыл бұрын
Where and when are the details of this study available?
@heartmuscletalks152
@heartmuscletalks152 3 жыл бұрын
Have a look here: www.jacc.org/doi/10.1016/j.jacc.2021.08.039